The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

A study that looks into the potential of wearables to non-invasively measure blood glucose has come up with promising results ...

Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...

DexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The ...

Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSense™, a nanotechnology-enabled wearable, mobile and software diagnostics platform, will ingest glucose data ...

Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last ...

CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.

But recently, CGMs designed for those without diabetes, including the Abbott Lingo and the Dexcom Stelo ... Additionally, these monitors often give false low blood sugar alerts, which can create ...

will ingest glucose data from Dexcom G7 Continuous Glucose Monitoring Systems (CGM) time synchronously alongside Nanowear’s previously FDA cleared cardiovascular biomarkers. The continuous ...